Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Finished Goods (2018 - 2025)

DarioHealth filings provide 8 years of Finished Goods readings, the most recent being $3.6 million for Q4 2025.

  • On a quarterly basis, Finished Goods fell 14.92% to $3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 14.92% decrease, with the full-year FY2025 number at $3.6 million, down 14.92% from a year prior.
  • Finished Goods hit $3.6 million in Q4 2025 for DarioHealth, down from $4.1 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $7.1 million in Q2 2022 to a low of $2.9 million in Q3 2021.
  • Median Finished Goods over the past 5 years was $4.2 million (2024), compared with a mean of $4.7 million.
  • Biggest five-year swings in Finished Goods: soared 378.79% in 2021 and later tumbled 38.77% in 2023.
  • DarioHealth's Finished Goods stood at $5.5 million in 2021, then grew by 19.88% to $6.6 million in 2022, then tumbled by 38.77% to $4.0 million in 2023, then rose by 3.53% to $4.2 million in 2024, then dropped by 14.92% to $3.6 million in 2025.
  • The last three reported values for Finished Goods were $3.6 million (Q4 2025), $4.1 million (Q3 2025), and $3.8 million (Q2 2025) per Business Quant data.